Author for Correspondence
Philip DiSalvo, MD
455 First Avenue
Room 123
New York, NY, 10016
Phone: 202-251-5964
Email: disalvo@gmail.com
All authors have made substantial contributions to conception and
design, acquisition of data, or analysis and interpretation of data;
have been involved in drafting the manuscript or revising it critically
for important intellectual content; and give final approval of the
version to be published.
The authors confirm that the PI for this paper is Dr. Robert S. Hoffman.
No interventions were performed with human subjects/patients nor were
substances administered to human subjects/patients. This study was
deemed exempt from comprehensive review by the NYC DOHMH IRB.
None of the authors have any financial conflicts of interest to declare.
Drs. Hoffman and Gosselin served on EXTRIP and participated in the
development of EXTRIP’s lithium guidelines.
The data that support the findings of this study are available on
request from the corresponding author. The data are not publicly
available due to privacy/ethical restrictions.